Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201–995

1987 ◽  
Vol 10 (6) ◽  
pp. 547-552 ◽  
Author(s):  
R. Oosterom ◽  
T. Verleun ◽  
P. Uitterlinden ◽  
H. A. Brunning ◽  
G. J. Bruining ◽  
...  
1988 ◽  
Vol 119 (3) ◽  
pp. 493-499 ◽  
Author(s):  
F. Takao ◽  
S. Kagawa ◽  
K. Sakamoto ◽  
A. Matsuoka

ABSTRACT The effect of maternal hyperglycaemia on the function of neonatal B cells was examined using a perifusion technique in pancreatic monolayer cultures of neonatal rats from normoglycaemic mothers (C), and those made slightly hyperglycaemic (SH) and highly hyperglycaemic (HH) by injection of streptozotocin. Monolayer cultures were kept for 7 days in medium containing 5·5 mmol glucose/l plus 1 mmol 2-deoxy-glucose/l. On day 0, B cells in the C group responded to 16·7 mmol glucose/l, 10 mmol leucine/l and 10 mmol 2-ketoisocaproate/l in a monophasic fashion with no significant rise in the second phase. However, compared with the C group, a significant increase in the second-phase secretion in response to glucose and 2-ketoisocaproate was observed in the SH group, although there was no difference in the first-phase secretion. In the HH group the insulin secretion was lower in the first phase but not in the second phase. After culture for 7 days, B cells in the C group showed a biphasic response to the secretagogues, with a great increase in the second-phase secretion. In the SH group, the second phase of insulin secretion was increased but the increment was far less than that in the C group. The secretory response was remarkably low in the HH group compared with other groups. From these results, we conclude that at an early stage of culture slight maternal hyperglycaemia causes a hypersensitivity of neonatal B cells but impairs the normal development of the function of B cells during culture, and that high hyperglycaemia results in impaired insulin secretion throughout the whole period of culture studied. J. Endocr. (1988) 119, 493–499


Author(s):  
WannJun Gan ◽  
OanhhHoang Do ◽  
Louise Cottle ◽  
Elena Kosobrodova ◽  
Justin CooperrWhite ◽  
...  

Diabetes ◽  
2005 ◽  
Vol 55 (1) ◽  
pp. 193-201 ◽  
Author(s):  
J. Yang ◽  
R. K. Wong ◽  
M. Park ◽  
J. Wu ◽  
J. R. Cook ◽  
...  

Diabetes ◽  
2005 ◽  
Vol 54 (2) ◽  
pp. 472-481 ◽  
Author(s):  
H. Noushmehr ◽  
E. D'Amico ◽  
L. Farilla ◽  
H. Hui ◽  
K. A. Wawrowsky ◽  
...  

Diabetes ◽  
2008 ◽  
Vol 57 (6) ◽  
pp. 1618-1628 ◽  
Author(s):  
M. Braun ◽  
R. Ramracheya ◽  
M. Bengtsson ◽  
Q. Zhang ◽  
J. Karanauskaite ◽  
...  

2021 ◽  
Vol 3 (1) ◽  
pp. 1-13
Author(s):  
Anasuya Ganguly ◽  

Diabetes is a group of diseases characterized by high levels of blood sugar for an extended period. Despite newer and effective therapy, current treatment is riddled with fundamental challenges. To overcome the adverse effects of existing drugs, regenerative medicine has emerged as an essential treatment, for which tissue engineering may serve as a foundation for the repair of pancreatic cells secreting insulin. Different polymeric scaffolds have been explored for pancreatic tissue engineering. In the current study, a continuation of our preceding work we attempt to test the role of previously synthesized agarose-chitosan coated silver nanocomposite scaffold (AG-CHNp) for the long-term growth of pancreatic cells. Pancreatic cells were isolated from BALB/c mice and were characterized by dithizone (DTZ) staining, real time polymerase chain reaction (RT-PCR), western blotting, and flow cytometry for characteristic pancreatic markers. The isolated population of cells was grown on scaffolds and its effectiveness towards insulin secretion was studied. The isolated population was found to be positive for glucagon, PDX-1 and Pax-4, while a 200-fold change transcript level of insulin was observed. The cells upon seeding on the scaffolds exhibited sustained growth and insulin secretion as confirmed by western blotting. Overall, the study demonstrates the suitability and application of AG-CHNp for pancreatic tissue engineering.


Sign in / Sign up

Export Citation Format

Share Document